Concise review: Leukemia stem cells in personalized medicine.
Concise review: Leukemia stem cells in personalized medicine.
复制标题
DOI:
10.1002/stem.1597
复制
发表时间:
2014-04
期刊:
影响因子:
5.2
通讯作者:
Allan, John N.
中科院分区:
文献类型:
--
作者:
Guzman, Monica L.;Allan, John N.
关键词:
Despite increased comprehension of AML pathogenesis, current treatment strategies have done little to improve upon standard induction chemotherapy to induce long-term remissions. Since the identification of the leukemic stem cell, efforts have been placed on identifying therapeutically actionable pathways that distinguish this increasingly important cellular compartment. With the advent of increased genome sequencing efforts and phenotypic characterization, opportunities for personalized treatment strategies are rapidly emerging. In this review, we highlight recent advances in the understanding of leukemic stem cell biology and their potential for translation into clinically relevant therapeutics. NF-kappa B activation, Bcl-2 expression, oxidative and metabolic state, and epigenetic modifications all bear their own clinical implications. With advancements in genetic, epigenetic, and metabolic profiling, personalized strategies may be feasible in the near future to improve outcomes for AML patients.
登录
查看更多内容
影响因子:
11.2
作者:
Chakrabarty A;Bhola NE;Sutton C;Ghosh R;Kuba MG;Dave B;Chang JC;Arteaga CL
通讯作者:
Arteaga CL
DOI:
10.1084/jem.20100523
发表时间:
2010-04-12
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Abdel-Wahab O;Levine RL
通讯作者:
Levine RL
影响因子:
50.3
作者:
Figueroa ME;Abdel-Wahab O;Lu C;Ward PS;Patel J;Shih A;Li Y;Bhagwat N;Vasanthakumar A;Fernandez HF;Tallman MS;Sun Z;Wolniak K;Peeters JK;Liu W;Choe SE;Fantin VR;Paietta E;Löwenberg B;Licht JD;Godley LA;Delwel R;Valk PJ;Thompson CB;Levine RL;Melnick A
通讯作者:
Melnick A
影响因子:
20.3
作者:
Guzman, ML;Neering, SJ;Jordan, CT
通讯作者:
Jordan, CT
影响因子:
82.9
作者:
Eppert, Kolja;Takenaka, Katsuto;Dick, John E.
通讯作者:
Dick, John E.